Author: Dr Peter Lind
Published: Mar 27 2013
The number of people with Alzheimer’s disease is expected to triple in the next 40 years.
According to a new study published in the February 6, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology, Alzheimer’s disease will triple.
The study found that the total number of people with Alzheimer’s dementia in 2050 is projected to be 13.8 million, up from 4.7 million in 2010. About 7 million of those with the disease would be age 85 or older in 2050.
Alzheimer’s disease is a progressive neurodegenerative disease. It happens when you lose neurons and their synapses between other neurons. When the brain is scanned you will see plaques where deposits of proteins accumulate. It’s like the lights are slowly going out over time.What’s going on with this increase in Alzheimer’s disease?
Before we start asking: “Is there a drug for that?, maybe we can prevent this neuro-metabolic process or at least slow it down.
Immuno-geneticist Dr. H. Hugh Fudenberg, MD (among the 15 most quoted scientists of this era with over 850 papers published in peer reviewed journals, http://www.nitrf.org/biblio.html , web site http://www.nitrf.org/fudenberg.html), in 1997 cited a ten year study conducted in the 1980's which demonstrated that those who have had five or more consecutive flu shots as opposed to one or two or no flu shots have a ten fold chance of developing Alzheimer's disease.
Did you get that? Getting the flu shot five or more consecutive times increased the chance of developing Alzheimer’s disease ten times.
This is something to seriously consider. There are metabolic consequences from chemicals and biochemical adjuncts added to the human body outside of normal metabolism.
Another development relates to blood sugar metabolism in the brain. Type 3 diabetes is a title proposed for Alzheimer's disease which results from resistance to insulin in the brain.
Researchers identified the possibility of a this new form of diabetes after finding that insulin is produced by the brain as well as the pancreas. Resistance in the brain to insulin and insulin-like growth factor is a key part of the progression of Alzheimer's disease. The brain needs a steady input of oxygen and glucose.
How many people have early Type 3 diabetes? We know the incidence of Type 2 diabetes is escalating in the U.S.
These are just two possible causes of dementia and early Alzheimer’s disease. Before we go looking for a cure we best look at these and other basic contributors to this fastest-growing threat to American health.
As the number of these cases increase the strain on the U.S. healthcare system will only rise, increasing calls for greater capacity in nursing homes and demand for skilled healthcare providers. It will also increase the strain on families, who often care for afflicted relatives until that burden becomes too great.
There is no time like the present to begin reducing the risk of Alzheimer’s disease.
Dr Peter Lind practices metabolic and neurologic chiropractic in his wellness clinic in Salem, Oregon. USA. He is the author of 3 books on health, one novel, and hundreds of wellness articles. His clinical specialty is in physical, nutritional, and emotional stress.
For more health tips go to www.wellnessreport.net
Please note that this article has been published on the basis that the content supplied is the original work of the provider. If you feel that copyright has been infringed, please contact the site administrator for review.
Please enter rgzj2 into this box: